Cardiovascular Drug Matching
Across
- 3. Antagonist at B1, B2, and alpha, may cause bronchoconstriction (decreases HR and SVR)
- 4. Venous and arteriolar vasodilator via NO
- 6. V1 receptor agonist (increases SVR)
- 7. Mainly venous dilator via NO, some arterial dilation
- 9. Phosphodiesterase inhibitor (increases intracellular Ca and CO, decreases SVR)
- 10. D1 agonist (low dose), B1 agonist (med dose), a1 agonist (high dose)
- 12. Antimuscarinic (increases HR)
- 13. B1 and B2 agonist (increases CO and decreases SVR)
- 14. Selective a1 agonist (increases SVR)
- 15. Causes release of norepinephrine, direct-acting effects (increases CO)
Down
- 1. B1 agonist, very small B2 agonism (increases CO)
- 2. Antimuscarinic, does not cross BBB
- 5. Rapid-onset, short-acting B1 antagonist
- 8. Agonist at B1, B2, a1, a2 (increases CO)
- 11. Agonist of B1, a1, and a2 (increases SVR)